Therapeutic efficacy of anti‐MMP9 antibody in combination with nab‐paclitaxel‐based chemotherapy in pre‐clinical models of pancreatic cancer

Matrix metalloproteinase 9 (MMP9) is involved in the proteolysis of extracellular proteins and plays a critical role in pancreatic ductal adenocarcinoma (PDAC) progression, invasion and metastasis. The therapeutic potential of an anti‐MMP9 antibody (αMMP9) was evaluated in combination with nab‐pacli...

Descripción completa

Detalles Bibliográficos
Autores principales: Awasthi, Niranjan, Mikels‐Vigdal, Amanda J., Stefanutti, Erin, Schwarz, Margaret A., Monahan, Sheena, Smith, Victoria, Schwarz, Roderich E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533474/
https://www.ncbi.nlm.nih.gov/pubmed/30941918
http://dx.doi.org/10.1111/jcmm.14242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533474/
https://www.ncbi.nlm.nih.gov/pubmed/30941918
http://dx.doi.org/10.1111/jcmm.14242

Ejemplares similares